Molecule intelOpportunity: ModerateEssential

Ketamine

46 brands · 29 companies · product forms

ATC: N01AX03 1 DRAP alert

Opportunity snapshot

Launch attractiveness
40
Market saturation
77
Price room
100
Regulatory risk
50
46
brands
29
companies
Rs 208.28
median price
36
price points
55.58x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 9%

Price room

Across observed sources and strengths
CheapestRs 40.22
MedianRs 208.28
Most expensiveRs 2,235.3
Spread55.58×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 55.58x across 36 trusted points (Rs 40.22-2235.3). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Ketamine — each links to its own medicine page.

Regulatory alerts

Safety exposurelatest 2025-01-10
Rapid Alert: CRACKDOWN AGAINST FALSIFIED PRODUCT

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(23) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

29 canonical companies and 46 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 55.58x across 36 trusted points (Rs 40.22-2235.3). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2025-01-10 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.